High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.1M
$10,136,356
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 Sell
2026-03-12
$2,756,468Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 Sell
|
2026-03-12 | $2,756,468Large | S | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2026-03-12
$275,875
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2026-03-12 | $275,875 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2026-03-12
$67,503
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2026-03-12 | $67,503 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2026-03-12
$181,388
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2026-03-12 | $181,388 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2026-03-12
$89,400
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2026-03-12 | $89,400 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2025-11-14
$689,688
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2025-11-14 | $689,688 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2025-11-14
$720,332
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2025-11-14 | $720,332 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2025-11-14
$816,244
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2025-11-14 | $816,244 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -96.5%
2025-11-14
$4,158,442Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -96.5%
|
2025-11-14 | $4,158,442Large | S | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2025-11-13
$708,774
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2025-11-13 | $708,774 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -82.3%
2025-11-13
$700,687
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -82.3%
|
2025-11-13 | $700,687 | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -65.5%
2025-11-13
$1,584,016Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -65.5%
|
2025-11-13 | $1,584,016Large | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -28.6%
2025-11-13
$936,743
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -28.6%
|
2025-11-13 | $936,743 | S | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
Other
2025-11-13
$63,099
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
Other
|
2025-11-13 | $63,099 | M | Form 4 |